Lender's $13M Atty Fee Reserve Bid In Eiger Ch. 11 Plan Nixed

By Clara Geoghegan · August 20, 2024, 7:52 PM EDT

A Texas bankruptcy judge on Tuesday mostly sided with life science company Eiger BioPharmaceuticals in estimating a secured lender's future claims, saying at a hearing that Eiger's Chapter 11 reserve for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Clara

November 21, 2024
How COVID Put TGI Fridays On The Path To Bankruptcy
November 20, 2024
Bankruptcy Panel Lets Paid Creditor Join Involuntary Ch. 7 Bid
November 20, 2024
Meet The Attys Driving Car Financing Co. Vroom's Ch. 11
November 19, 2024
True Value Can Reject Leases Following $153M Ch. 11 Sale
November 19, 2024
College Decor Co. Dormify Hits Ch. 11 With Up To $50M Debt
November 14, 2024
Louisiana Oil Field Co. Hits Ch. 11 Again With $115M Debt
November 13, 2024
Judge Nixes Tort Committee Bid In Steward Health Chapter 11
November 12, 2024
Biolase Strikes Deal With Creditors For Sale, Final DIP
November 08, 2024
Under The Radar: Bankruptcy News You May Have Missed
November 07, 2024
Boy Scouts Judge OKs Incarcerated Survivor's Late Claim